Are you long or short? Man up to this question. Why you here? If you are short, that's fine. Everyone has to try to make a buck.
Other question, what do you think of this CART therapy being investigated by Juno?
Yes, I agree with you that overall market contributed to this pop up along with other biotech's I follow. Regarding fundamentals I see none here as we haven't received any info. Someone here posted that Goldman was going to provide some stellar news by year end. What happened?
If NWBO can't bring attention to itself with their good results then I highly doubt these companies can do much more for them. The stock is NOT impressing me technically and don't care for the lack of transparency the longer I stay here.
A 1000 per share? Ummmm, I don't see anyone in the markets seeing that and they sure aren't buying with any conviction. I don't see any breakouts on the chart. We're moving sideways between low 6 and high 4's. Technicals do not support many longs beliefs here. I wish it did. :(
I hope LP has something good to say tomorrow! GLTA.
Good stuff and very interesting. Thanks. Now lets see the stock move. Waiting.
I'll take it! Anyday! On Schwab i had 30 day avg around 440,000. I think we might get to it. Not sure. It is nice to be in the 5's even if the technicals aren't the greatest. I'd like to see some bigger volume, but maybe the shareholder meeting will give us a surprise. More companies getting into immunotherapy and I'd like to see NWBO hurry up and get their vaccines approved ASAP.
Abeta, that's fine and dandy, but these individual case studies are getting old. They're losing their effect. We need some concrete dates and numbers. I'm not here to sit with a big position for 5 years for the stock to move back to 7-8. Forget it. I had to pass on Blue when it was in the low 30's with the pullback we had a month and half ago. I missed out with NWBO being my core holding. I"m with you on the great technology, but am not with you on getting brainwashed by management and their tidbits of info. Not good. I'm a veteran investor/trader and have seen many of these CEO and managements do things in their own interests. I think independently and don't need anyone to agree with me. This saved me from a huge loss recently with GTAT. I took a loss in the 12-13 range and the stock later went bankrupt. There were people there that lost all there monies regardless how much they cheer leaded. I will see what Linda says this Friday. If not convincing, I will bail and keep 5-7000 shares as a Hail Mary and not worry about that small change.
Any thoughts? I'd like to hear some type of progress report on Germany and England. Germany in particular. Also, where we are at with these phase studies. Something a little more concrete. The individual reports of success are nice, but how about something more reflective of the whole studies under way.
As a shareholder, we deserve to start getting some bones tossed our way. When I hear the CEO saying our stock is inexpensive, that doesn't count. That's pandering. For any technicians out there the chart is HORRIBLE. I have scaled in a little more under 5 and low 5's. That's it. Now I sit and wait for Friday.
What I don't understand is if this is such a novel technology and results so stunning, I don't understand why this stock is hovering higher. I'm long on this puppy, but keeping an open mind. I'm not crazy about this downtrend again especially after presentations showing favorable results.
LOL. Good one! To me this validates the use of dendritic cells and using the body's immune system (natural) to attack various illnesses.
This is an interesting article and gives justification to use of dendritic cells for treating cancers and so forth...
Cancer is deadly because it is able to evade attack from the body's immune system, which allows tumors to flourish and spread. Now scientists are enlisting 3-D technology in hopes of creating a vaccine that could boost the immune system, enabling them to fight and even prevent the disease.
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard's School of Engineering and Applied Sciences devised the technique.
It involves injecting programmable biomaterial, which would spontaneously assemble inside the body into a 3-D structure that could fight and even help prevent cancer.
So far, the researchers have tested the 3-D vaccine only in mice, but it has proven highly effective. An experiment showed that the injectable 3-D scaffold recruited and attracted millions of dendritic cells (which are messenger cells for the immune system) in a host mouse, before dispersing the cells to the lymph nodes and triggering a powerful immune response.
"Injectable immunotherapies that use programmable biomaterials as a powerful vehicle to deliver targeted treatment and preventative care could help fight a whole range of deadly infections, including common worldwide killers like HIV and Ebola, as well as cancer," said Dr. Donald Ingber, the founding director of the Wyss Institute.
Exactly. What else? Until then we are stuck in this trading range. I'd love to see a nice pop with convincing volume, but nothing yet.
All good questions and something I will be watching. I attended a shareholder meeting of a now defunct internet company 15 years ago and I tell ya, I have seen the shareholders mostly behave as sheep (myself included) and the company provides their information for future. The interesting thing was there was one guy there that drilled the CEO and rightly so. I recall a lot of people disapproving this guy, but he was in the right. Couple of years later the company (internet services) went belly up. Same should apply to this management. I'm sticking to my guns on this one. If no news until Dec. 31st, I sell off part my position and go elsewhere. I will still hold several thousand shares as a Hail Mary as there is some positive news out there than the shorts would have us disbelieve, but I also am not going to wait forever as all these new immunotherapies are popping up. The German news is what I'm most excited about as it leads to money. Revenue. They can become a profitable company and that can fuel their other studies and expansion plans. GLTA.
Any guesses on what will be discussed? Got this from my broker. We need to get some hard info soon on Germany or we're going to continue this trickle downtrend.
Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting
NORTHWEST BIOTHERAPEUTICS, INC. Annual Meeting of Stockholders
MEETING DATE: December 19, 2014
For holders as of: November 14, 2014
I wish your brother and family the best. I hope his present treatments suffice and excellent thinking about using supplements. As a pharmacist, I think too few of our health professionals put any belief into using them. I would include salmon or other low mercury fish twice a week, but stay away from the high mercury fish such as swordfish, tuna, etc. Also, read something interesting about a study where folks did exercise when getting chemo vs not, and they found the one's that exercised had better results. They hypothesized it must be the increase of blood flow transferring the chemo to the cancer cells. Fruits and veggies too. I take care of a parent with Alzheimer's and if I just went by what the neurologist recommended, she'd be dead last year easy. You have to do your research in our age of fast food medicine in America.
Have you checked into the German treatment with DCVax? If so can you tell us what the communication is and will the Aussie government help with payments or do they (Germans) offer a discounted rate for out of country patients?
70 Grand seems right to me. They have a socialized medical system and will barter it. I go with 70. if it get higher I will be very surprised.